Appleman James R. 4
4 · ANADYS PHARMACEUTICALS INC · Filed Jan 24, 2011
Insider Transaction Report
Form 4
Appleman James R.
SVP, Research & CSO
Transactions
- Award
Stock Option (Right to Buy)
2011-01-20+50,000→ 50,000 totalExercise: $1.29From: 2012-01-20Exp: 2021-01-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]50% of the shares subject to the option will become exercisable on January 20, 2012 with the remaining shares subject to the option vesting in equal monthly installments evenly over the next year such that all shares subject to the option will be fully vested and exercisable as of January 20, 2013.